Stay updated on RAS and Coagulopathy in COVID19 Clinical Trial
Sign up to get notified when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.

Latest updates to the RAS and Coagulopathy in COVID19 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter now lists Revision: v3.3.3 added. HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPublication description updated from 'are about the study results' to 'are about the results of the study', and a page footer shows 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the temporary notice about government funding and operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedNo changes to core study content were detected; only minor visual/layout updates to the page were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%

- Check98 days agoChange DetectedCore content updated to emphasize specific chemical categories and compounds; broader/older terms removed and version bumped to v3.1.0.SummaryDifference0.9%

Stay in the know with updates to RAS and Coagulopathy in COVID19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.